Biogen Inc (NASDAQ:BIIB)

270.58
Delayed Data
As of Mar 05
 +7.01 / +2.66%
Today’s Change
223.25
Today|||52-Week Range
363.92
+10.50%
Year-to-Date
Biogen Inc. (BIIB) Down 1.4% Since Last Earnings Report: Can It Rebound?
Mar 05 / Zacks.com - Paid Partner Content
2 Best Pharma Stocks to Buy Right Now
Feb 23 / MotleyFool.com - Paid Partner Content
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal
Mar 01 / Zacks.com - Paid Partner Content
Where Will Biogen Be in 5 Years?
Feb 23 / MotleyFool.com - Paid Partner Content
Ionis (IONS) Q4 Earnings Decline Y/Y, Sales Beat Estimates
Feb 25 / Zacks.com - Paid Partner Content
Should Investors Worry About Moderna's Vaccine Delays?
Feb 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close263.57
Today’s open265.74
Day’s range262.75 - 273.33
Volume47,644
Average volume (3 months)1,616,365
Market cap$41.2B
Data as of 4:00pm ET, 03/05/2021

Growth & Valuation

Earnings growth (last year)-21.00%
Earnings growth (this year)-45.09%
Earnings growth (next 5 years)-4.99%
Revenue growth (last year)-2.82%
P/E ratio10.9
Price/Sales3.20
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
MRNAModerna Inc+0.02+0.02%
ILMNIllumina Inc-0.75-0.19%
EXASExact Sciences Corp+0.58+0.48%
----
Data as of 5:51pm ET, 03/05/2021

Financials

Next reporting dateApril 27, 2021
EPS forecast (this quarter)$5.07
Annual revenue (last year)$12.4B
Annual profit (last year)$4.0B
Net profit margin32.38%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts